Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010861085> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2010861085 endingPage "36391" @default.
- W2010861085 startingPage "36387" @default.
- W2010861085 abstract "Regulators of G protein signaling (RGS proteins) are well known to accelerate G protein GTPase activity in vitro and to promote G protein desensitization in vivo. Less is known about how RGS proteins are themselves regulated. To address this question we purified the RGS in yeast, Sst2, and used electrospray ionization mass spectrometry to identify post-translational modifications. This analysis revealed that Sst2 is phosphorylated at Ser-539 and that phosphorylation occurs in response to pheromone stimulation. Ser-539 lies within a consensus mitogen-activated protein (MAP) kinase phosphorylation site, Pro-X-Ser-Pro. Phosphorylation is blocked by mutations in the MAP kinase genes (FUS3, KSS1), as well as by mutations in components needed for MAP kinase activation (STE11, STE7, STE4, STE18). Phosphorylation is also blocked by replacing Ser-539 with Ala, Asp, or Glu (but not Thr). These point mutations do not alter pheromone sensitivity, as determined by growth arrest and reporter transcription assays. However, phosphorylation appears to slow the rate of Sst2 degradation. These findings indicate that the G protein-regulated MAP kinase in yeast can act as a feedback regulator of Sst2, itself a regulator of G protein signaling. Regulators of G protein signaling (RGS proteins) are well known to accelerate G protein GTPase activity in vitro and to promote G protein desensitization in vivo. Less is known about how RGS proteins are themselves regulated. To address this question we purified the RGS in yeast, Sst2, and used electrospray ionization mass spectrometry to identify post-translational modifications. This analysis revealed that Sst2 is phosphorylated at Ser-539 and that phosphorylation occurs in response to pheromone stimulation. Ser-539 lies within a consensus mitogen-activated protein (MAP) kinase phosphorylation site, Pro-X-Ser-Pro. Phosphorylation is blocked by mutations in the MAP kinase genes (FUS3, KSS1), as well as by mutations in components needed for MAP kinase activation (STE11, STE7, STE4, STE18). Phosphorylation is also blocked by replacing Ser-539 with Ala, Asp, or Glu (but not Thr). These point mutations do not alter pheromone sensitivity, as determined by growth arrest and reporter transcription assays. However, phosphorylation appears to slow the rate of Sst2 degradation. These findings indicate that the G protein-regulated MAP kinase in yeast can act as a feedback regulator of Sst2, itself a regulator of G protein signaling. G-protein coupled receptor kinase mitogen-activated protein regulator of G protein signaling solid phase extraction nickel nitrilotriacetic acid mass spectrometry polyacrylamide gel electrophoresis All eukaryotic cells respond to external signals through cell surface receptors linked to heterotrimeric G proteins. In humans, G protein-linked receptors can detect hormones, neurotransmitters, and sensory stimuli (odors, taste, light). In the yeast Saccharomyces cerevisiae, G protein linked pheromone receptors mediate events required for mating and cell fusion. Upon receptor stimulation, the G protein binds GTP and undergoes subunit dissociation. The Gα subunit or the Gβγ subunit dimer can then propagate the signal through a variety of effector enzymes or ion channels. Upon GTP hydrolysis, the G protein subunits reassociate and signaling stops. Additional proteins can modulate this cycle of G protein activation and inactivation. For instance, G protein-coupled receptor kinases (GRKs)1 and arrestins promote desensitization through phosphorylation, uncoupling, and internalization of the receptor (1Lefkowitz R.J. J. Biol. Chem. 1998; 273: 18677-18680Abstract Full Text Full Text PDF PubMed Scopus (906) Google Scholar). It is now evident that G proteins are also subject to desensitization and that this process involves members of the RGS protein family. The contribution of RGS proteins in vivo has been established through genetic analysis in yeast and nematodes. In yeast, disruption of the RGS gene SST2 can increase pheromone sensitivity by 100–300-fold (2Dohlman H.G. Thorner J. J. Biol. Chem. 1997; 272: 3871-3874Abstract Full Text Full Text PDF PubMed Scopus (450) Google Scholar). The mechanism of RGS action has also been well characterized through detailed biochemical and x-ray crystallographic analysis of purified components (3Tesmer J.J. Berman D.M. Gilman A.G. Sprang S.R. Cell. 1997; 89: 251-261Abstract Full Text Full Text PDF PubMed Scopus (687) Google Scholar, 4Berman D.M. Gilman A.G. J. Biol. Chem. 1998; 273: 1269-1272Abstract Full Text Full Text PDF PubMed Scopus (445) Google Scholar). Stop flow fluorescence measurements reveal that RGS proteins can accelerate Gα GTPase activity by up to 1000-fold (5Lan K.L. Sarvazyan N.A. Taussig R. Mackenzie R.G. DiBello P.R. Dohlman H.G. Neubig R.R. J. Biol. Chem. 1998; 273: 12794-12797Abstract Full Text Full Text PDF PubMed Scopus (150) Google Scholar). How are RGS proteins themselves regulated? Some RGS genes, includingSST2, are transcriptionally induced by G protein activation (6Dietzel C. Kurjan J. Mol. Cell. Biol. 1987; 7: 4169-4177Crossref PubMed Scopus (161) Google Scholar). Virtually nothing is known about how these proteins are regulated post-translationally, however. In particular, it is not known if RGS proteins are phosphorylated or otherwise modified in response to cell stimulation. To address this question, we examined whether Sst2 undergoes any chemical modifications in vivo. Our analysis reveals that Sst2 is stoichiometrically phosphorylated at Ser-539, in response to pheromone stimulation, and in a Fus3-dependent manner. Phosphorylation appears to stabilize the protein, thereby augmenting the transcriptional induction that occurs in response to pheromone stimulation. S. cerevisiae stains used in this study are BJ2168 (MATa ura3–52 leu2-Δ1 trp1-Δ63 prb1–1122 prc-1–407 pep4–3), BJSST2 (sst2-Δ2, derived from BJ2168) (7Dohlman H.G. Song J. Ma D. Courchesne W.E. Thorner J. Mol. Cell. Biol. 1996; 16: 5194-5209Crossref PubMed Google Scholar), YPH 499 (MATa ura3–52 lys2–801 am ade2–101 oc trp1-Δ63 his3-Δ200 leu2-Δ1), and MPY576fc (MATasst2::NEO fus1::FUS1-HIS3 fus2::FUS2-CAN1 far1::LYS2 ura3 his3 leu2 trp1 lys2 ade2 can1). Signaling mutants were derived from YPH499 and are designated YDK101 (ste2::HIS3, from J. Thorner, University of California), YSB1 (gpa1 G302S, from S. Burchett and H. G. D.) 2S. Burchett and H. G. Dohlman, manuscript in preparation. (8Apanovitch D.M. Iiri T. Karasawa T. Bourne H.R. Dohlman H.G. J. Biol. Chem. 1998; 273: 28597-28602Abstract Full Text Full Text PDF PubMed Scopus (23) Google Scholar), YDM400 (sst2-Δ2) (7Dohlman H.G. Song J. Ma D. Courchesne W.E. Thorner J. Mol. Cell. Biol. 1996; 16: 5194-5209Crossref PubMed Google Scholar), YTG4 (ste4::hisG, this laboratory), MHY16 (ste18::LEU2) (9Hasson M.S. Blinder D. Thorner J. Jenness D.D. Mol. Cell. Biol. 1994; 14: 1054-1065Crossref PubMed Google Scholar), YTG20 (ste20::LEU2) (10Ramer S.W. Davis R.W. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 452-456Crossref PubMed Scopus (169) Google Scholar), YTG11 (ste11::hisG) (9Hasson M.S. Blinder D. Thorner J. Jenness D.D. Mol. Cell. Biol. 1994; 14: 1054-1065Crossref PubMed Google Scholar), JTY2556 (ste7::ADE2, from J. Thorner), YDM600 (kss1::hisG) (11Ma D. Cook J.G. Thorner J. Mol. Biol. Cell. 1995; 6: 889-909Crossref PubMed Scopus (67) Google Scholar), YDM200 (fus3::LEU2) (11Ma D. Cook J.G. Thorner J. Mol. Biol. Cell. 1995; 6: 889-909Crossref PubMed Scopus (67) Google Scholar), YDM300 (kss1::hisG, fus3::LEU2) (11Ma D. Cook J.G. Thorner J. Mol. Biol. Cell. 1995; 6: 889-909Crossref PubMed Scopus (67) Google Scholar), YDK12/JDY3 (ste12::LEU2) (12Davis J.L. Kunisawa R. Thorner J. Mol. Cell. Biol. 1992; 12: 1879-1892Crossref PubMed Scopus (150) Google Scholar). Plasmid pAD4M-SST2-his was constructed by replacing theBssHII-HindIII fragment of SST2 in pAD4M (13Dohlman H.G. Apaniesk D. Chen Y. Song J. Nusskern D. Mol. Cell. Biol. 1995; 15: 3635-3643Crossref PubMed Scopus (166) Google Scholar) with the corresponding sequence from pQE60-SST2-his (14Apanovitch D.M. Slep K.C. Sigler P.B. Dohlman H.G. Biochemistry. 1998; 37: 4815-4822Crossref PubMed Scopus (97) Google Scholar). Plasmid pRS316-ADH-SST2 contains SST2 under the control of a constitutive promoter from ADH1 and is described in Ref. 14Apanovitch D.M. Slep K.C. Sigler P.B. Dohlman H.G. Biochemistry. 1998; 37: 4815-4822Crossref PubMed Scopus (97) Google Scholar. pRS315-SST2 contains SST2 under the control of its own promoter (14Apanovitch D.M. Slep K.C. Sigler P.B. Dohlman H.G. Biochemistry. 1998; 37: 4815-4822Crossref PubMed Scopus (97) Google Scholar). Plasmid pGA1905 contains a myc epitope-taggedFUS3 K42R “kinase dead” mutant, as described in Ref. 15Zhou Z. Gartner A. Cade R. Ammerer G. Errede B. Mol. Cell. Biol. 1993; 13: 2069-2080Crossref PubMed Scopus (120) Google Scholar. SST2 mutants were obtained using the QuickChange mutagenesis kit (Stratagene) and confirmed by DNA sequencing. BJ2168 cells transformed with pAD4M-SST2-his were grown to A600 nm ∼ 0.8 and treated with 2.5 μm α-factor, as indicated. Cells were chilled, harvested by centrifugation, rapidly frozen in liquid nitrogen, and thawed in urea buffer (6 m urea, 100 mmNa2H2PO4, 10 mm Tris, 10 mm 2-mercaptoethanol, pH 8.0), 250 mm NaCl, 15 mm imidazole (at 250 ml/6 liter of medium) at room temperature. Cells were further disrupted using a stainless steel beadbeater (Biospec) packed in ice and salt, with 10 × 30-s pulses, once every 90 s. The remaining procedures were carried out at room temperature. The disrupted cells were rocked for 60–90 min, then clarified by centrifugation 3840 × g, 15 min and paper filtration (Whatman No. 1). The soluble material was mixed with 3 ml of equilibrated Superflow Ni2+-NTA resin (Qiagen) for 60–90 min, then packed into a HR 10/10 (Amersham Pharmacia Biotech) column and washed using 10 column volumes (CV) of urea buffer, 250 mm NaCl, 15 mm imidazole at 1.5 ml/min, followed by 10 CV urea buffer at 1 ml/min. Sst2 was eluted in 10 CV of urea buffer, 75 mm imidazole at 1 ml/min. The eluate was mixed with 2 ml of equilibrated Mono Q resin (Amersham Pharmacia Biotech) for 60 min, then packed into a HR 10/10 column and washed with 5 CV of urea buffer at 1 ml/min, then 7.5 CV of urea buffer and a linear gradient (0–60 mm) of NaCl at 0.5 ml/min and 7.5 CV 60 mm NaCl urea buffer at 0.5 ml/min. Sst2 was eluted with 15 CV urea buffer, 1 m NaCl at 0.5 ml/min. Peak fractions were pooled, concentrated, and desalted using an Ultrafree-30 (Millipore) filter. The final purified product (500 μl) was resolved by sodium dodecyl sulfide-polyacrylamide gel electrophoresis (SDS-PAGE) and silver staining (Silver Stain Plus, Bio-Rad). Except where indicated, 16-cm 8% acrylamide gels were used to resolve the 82- and 84-kDa species of Sst2. Antibodies and conditions for immunoblot detection of Sst2 are described elsewhere (7Dohlman H.G. Song J. Ma D. Courchesne W.E. Thorner J. Mol. Cell. Biol. 1996; 16: 5194-5209Crossref PubMed Google Scholar). Each silver-stained protein band (∼1 μg) was excised (20-cm gel) and transferred to a 0.5-ml microcentrifuge tube and destained with a 1:1 solution of 30 mm potassium ferricyanide and 100 mm sodium thiosulfate for 2 min. The gel was washed four times with Milli-Q water, cut into small pieces, washed three times for 8 min each with 12.5 mm ammonium bicarbonate, 50% acetonitrile and Speedvac-lyophilized. Samples were reconstituted with 40 μl of 12.5 ng/ml endoproteinase Asp-N or pepsin (Roche Molecular Biochemicals), incubated on ice for 40 min, then at 37 °C overnight. Peptides were extracted three times with 40 μl of 5% acetic acid, 50% acetonitrile. All four supernatants were pooled, and the solution was dried under vacuum and reconstituted in 10 μl of capillary electrophoresis buffer (10 mm acetic acid, 10% MeOH). Solid phase extraction (SPE) capillary electrophoresis electrospray ionization tandem mass spectrometry was performed essentially as described (16Figeys D. Ducret A. Yates III, J.R. Aebersold R. Nat. Biotechnol. 1996; 14: 1579-1583Crossref PubMed Scopus (167) Google Scholar). The SPE cartridge consisted of Spherisorb C-18 material between two Teflon membranes inside a Teflon tube (17Figeys D. Zhang Y. Aebersold R. Electrophoresis. 1998; 19: 2338-2347Crossref PubMed Scopus (58) Google Scholar). The reconstituted peptide mixture was loaded on the SPE cartridge at 1 μl/min. The concentrated peptides were washed for 10 min and eluted by applying a small plug of 67% acetonitrile, 3 mm acetic acid across the SPE cartridge. Separation was achieved by capillary electrophoresis in a 50 μm inner diameter and 150 μm outer diameter fused silica capillary 40 cm in length. Separated analytes were electrosprayed into a Finnigan MAT LCQ ion trap mass spectrometer and detected in the MS mode. Ion signals above a predetermined threshold automatically triggered the instrument to switch from MS to MS/MS mode for generating collision-induced dissociated spectra (data-dependent MS/MS). The ion trap was run with automatic gain, and the MS scan was performed in three segments from 400–900, 900–1400, and 1400–2000 atomic mass units, respectively. To determine the phosphorylation site in the protein, the generated collision-induced dissociated spectra were searched against a yeast genomic sequence data base using the SEQUEST search program (18Yates III, J.R. Eng J.K. McCormack A.L. Schieltz D. Anal. Chem. 1995; 67: 1426-1436Crossref PubMed Scopus (1110) Google Scholar). To determine whether Sst2 undergoes post-translational modification, we isolated a His-tagged version of the protein from both pheromone-stimulated and -unstimulated cells. Cells were disrupted in a denaturing buffer containing 6 m urea, so as to fully solubilize Sst2 and to preserve any modifications. Sst2 was then purified by sequential Ni2+-NTA affinity and Mono Q-Sepharose ion exchange chromatography, and resolved by gel electrophoresis. As shown in Figs. 1 and2, Sst2 from control (unstimulated) cells migrates at the predicted size of ∼82 kDa, while Sst2 from pheromone-stimulated cells migrates as a doublet of ∼82 and 84 kDa. Both products were confirmed by immunoblotting with anti-Sst2 antibodies (Fig. 1 A, bottom) and by mass spectrometry sequencing (Fig. 1 B).FIG. 2Phosphorylation requires Fus3 and Ser-539. A, to determine whether Ser-539 is phosphorylated in vivo, this residue was replaced with Ala (A), Glu (E), Asp (D), or Thr (T). BJ2168 cells expressing wild-type or mutant Sst2 (pAD4M-SST2-His) were treated with α-factor for 1 h (“+”). Cells were lysed in SDS-PAGE sample buffer, and the conversion of Sst2 to the phosphorylated species was monitored by 8% SDS-PAGE and immunoblotting, using anti-Sst2 antibodies (7Dohlman H.G. Song J. Ma D. Courchesne W.E. Thorner J. Mol. Cell. Biol. 1996; 16: 5194-5209Crossref PubMed Google Scholar).B, to determine the time course of Sst2 phosphorylationin vivo, BJSST2 cells containing pRS316-ADH-SST2 were exposed to 2.5 μm α-factor for the indicated times, lysed in SDS-PAGE sample buffer, and monitored by immunoblotting.C, to determine which signaling components are needed for Sst2 phosphorylation, extracts were prepared from YPH499 or YPH499-based mutant strains, containing pRS316-ADH-SST2, and lacking the α-factor receptor (STE2), the G protein β subunit (STE4), the Gγ subunit (STE18), the MAP kinase kinase kinase kinase (STE20), the MAP kinase kinase kinase (STE11), the MAP kinase kinase (STE7), the functionally redundant MAP kinases (FUS3, KSS1), or the downstream transcription factor (STE12). Thegpa1 G302S product cannot bind to Sst2, but is otherwise fully functional (24DiBello P.R. Garrison T.R. Apanovitch D.M. Hoffman G. Shuey D.J. Mason K. Cockett M.I. Dohlman H.G. J. Biol. Chem. 1998; 273: 5780-5784Abstract Full Text Full Text PDF PubMed Scopus (99) Google Scholar). Fus3K42R lacks kinase activity (31Elion E.A. Satterberg B. Kranz J.E. Mol. Biol. Cell. 1993; 4: 495-510Crossref PubMed Scopus (214) Google Scholar). Cells were treated with 2.5 μm α-factor for 1 h as indicated (“+”), and subjected to immunoblotting.View Large Image Figure ViewerDownload (PPT) The appearance of a new higher molecular weight species suggested that Sst2 undergoes some form of stimulus-dependent post-translational modification. To characterize this further, each band was excised from the gel, subjected to limited proteolysis, and analyzed by electrospray ionization tandem mass spectrometry. As indicated in Fig. 1 B, a phospho-Ser at position 539 was present in the 84-kDa band. The corresponding nonphosphorylated peptide was obtained from the 82-kDa bands, from either stimulated or unstimulated cells (data not shown). To confirm that phosphorylation occurs on Ser-539, we replaced this amino acid with Ala, Glu, Asp, or Thr. With the exception of Thr, these residues cannot be phosphorylated by protein kinases. The acidic residues Asp and Glu can often substitute for the negatively charged phospho-Ser (19Seger R. Krebs E.G. FASEB J. 1995; 9: 726-735Crossref PubMed Scopus (3207) Google Scholar). As expected, the Ser-539 → Thr mutation preserved the pheromone-dependent mobility shift, while the Ala, Asp, and Glu mutations blocked the shift completely (Fig. 2 A). These data indicate that Sst2 undergoes a stimulus-dependent phosphorylation at Ser-539 and that Ser-539 phosphorylation causes the gel mobility shift. Ser-539 lies within an ideal consensus sequence (Pro-X-Ser-Pro) for phosphorylation by MAP kinases (19Seger R. Krebs E.G. FASEB J. 1995; 9: 726-735Crossref PubMed Scopus (3207) Google Scholar). Indeed, the pheromone signaling pathway involves at least one MAP kinase family member, Fus3 (20Sprague Jr., G.F. Genes Dev. 1998; 12: 2817-2820Crossref PubMed Scopus (37) Google Scholar). To determine whether Sst2 is a substrate for Fus3 in vivo, we examined whether Sst2 phosphorylation requires Fus3 expression or activity. We first established the time course of Sst2 phosphorylation (Fig. 2 B). We then tested whether Sst2 is phosphorylated in cells lacking the FUS3 gene or any of the other known components of the signaling cascade (Fig. 2 C). As predicted, Sst2 failed to undergo phosphorylation in cells lacking FUS3, provided that KSS1 (another MAP kinase that can partially rescue a fus3 mutant) was also deleted (21Madhani H.D. Styles C.A. Fink G.R. Cell. 1997; 91: 673-684Abstract Full Text Full Text PDF PubMed Scopus (364) Google Scholar, 22Cook J.G. Bardwell L. Thorner J. Nature. 1997; 390: 85-88Crossref PubMed Scopus (221) Google Scholar). Phosphorylation was not restored by a Fus3 mutant (Lys-42 → Arg) that lacks kinase activity. Phosphorylation was also abolished by mutations that block expression of the upstream MAP kinase kinase (MAPKK, Ste7) or MAPKK kinase (Ste11). This was expected, since both Ste7 and Ste11 are required for Fus3 activity (23Gartner A. Nasmyth K. Ammerer G. Genes Dev. 1992; 6: 1280-1292Crossref PubMed Scopus (220) Google Scholar). Phosphorylation was preserved in a Gpa1Gly-302 → Ser mutant that cannot bind Sst2 (24DiBello P.R. Garrison T.R. Apanovitch D.M. Hoffman G. Shuey D.J. Mason K. Cockett M.I. Dohlman H.G. J. Biol. Chem. 1998; 273: 5780-5784Abstract Full Text Full Text PDF PubMed Scopus (99) Google Scholar), as well as in mutants lacking the MAPKKK kinase Ste20 or the transcription factor (and Fus3 substrate) Ste12. Deletion of the pheromone receptor Ste2 blocks the pheromone-mediated response, but also leads to elevated basal signaling (9Hasson M.S. Blinder D. Thorner J. Jenness D.D. Mol. Cell. Biol. 1994; 14: 1054-1065Crossref PubMed Google Scholar) and Sst2 phosphorylation (Fig. 2 C). Thus, the only components of the pathway necessary for Sst2 phosphorylation are those needed to activate MAP kinase and the MAP kinase itself. Taken together, these findings indicate that Sst2 is phosphorylated in vivo by Fus3. Loss-of-function mutations in Sst2 are well known to increase pheromone sensitivity (25Chan R.K. Otte C.A. Mol. Cell. Biol. 1982; 2: 11-20Crossref PubMed Scopus (251) Google Scholar). To determine whether MAP kinase phosphorylation has any effect on pheromone signaling in vivo, we tested the ability of the Ser-539 mutants to regulate the pheromone response pathway, using a reporter transcription assay. As shown in Fig. 3 A, pheromone-induced gene transcription (using the FUS1 promoter linked to the essential HIS3 gene) was unaffected by any of the Ser-539 substitutions. Likewise, no difference was seen using an alternative pheromone bioassay, the growth inhibition plate assay (halo assay, Fig. 3 B) (26Pausch M.H. Price L.A. Kajkowski E.M. Strnad J. Delacruz F. Heinrich J.A. Ozenberger B.A. Hadcock J.R. Lynch K.R. Identification and Expression of G Protein-coupled Receptors. Wiley-Liss, New York1998: 196-212Google Scholar, 27Sprague Jr., G.F. Methods Enzymol. 1991; 194: 77-93Crossref PubMed Scopus (226) Google Scholar). Like many cell regulators, Sst2 has a short half-life in vivo (7Dohlman H.G. Song J. Ma D. Courchesne W.E. Thorner J. Mol. Cell. Biol. 1996; 16: 5194-5209Crossref PubMed Google Scholar, 28Kim E. Arnould T. Sellin L. Benzing T. Comella N. Kocher O. Tsiokas L. Sukhatme V.P. Walz G. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 6371-6376Crossref PubMed Scopus (145) Google Scholar). Some regulatory factors (e.g. cyclins, cyclin inhibitors) are targeted for destruction by phosphorylation and, in some cases, by ubiquitination (28Kim E. Arnould T. Sellin L. Benzing T. Comella N. Kocher O. Tsiokas L. Sukhatme V.P. Walz G. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 6371-6376Crossref PubMed Scopus (145) Google Scholar). Thus, we considered whether phosphorylation of Ser-539 contributes to Sst2 proteolysis. Cells were transformed with plasmids containing wild-type or the 539 mutant forms of Sst2, under the control of a constitutive promoter (ADH1, to prevent pheromone-mediated changes in SST2transcription). Cells were treated with cycloheximide to block new protein synthesis and sampled at various times. As shown in Fig. 3 C, the overall levels of Sst2 drop rapidly when translation is blocked, but the decrease is most pronounced for thenonphosphorylated (82-kDa) species. An alternative explanation, that loss of the 82-kDa species is due to increased phosphorylation, is improbable, since there is no concomitant increase in the 84-kDa form of the protein. Surprisingly, all of the 539 mutants degraded at rates comparable with the phosphorylated form of Sst2 (data not shown). These data suggest that Sst2 is rapidly degraded, except when Ser-539 is phosphorylated or replaced with another amino acid. One of the defining characteristics of desensitization is feedback inhibition. One way this is accomplished is through increased expression of factors that can attenuate the signal. Indeed it is well known that increased expression of Sst2 will inhibit the pheromone response (7Dohlman H.G. Song J. Ma D. Courchesne W.E. Thorner J. Mol. Cell. Biol. 1996; 16: 5194-5209Crossref PubMed Google Scholar). It is also known that pheromone stimulation leads to increased transcription of SST2 (6Dietzel C. Kurjan J. Mol. Cell. Biol. 1987; 7: 4169-4177Crossref PubMed Scopus (161) Google Scholar). Our findings indicate that pheromone stimulation promotes increased stabilization of the protein, and this is achieved in part through phosphorylation at Ser-539. The combined effect of transcriptional induction and protein stabilization should allow for sustained expression of Sst2 and at a lower energy expenditure than transcriptional induction alone. Consistent with this interpretation, we have found that expression of endogenous Sst2 is induced by pheromone (7Dohlman H.G. Song J. Ma D. Courchesne W.E. Thorner J. Mol. Cell. Biol. 1996; 16: 5194-5209Crossref PubMed Google Scholar), and the induced protein exists predominantly in the 84-kDa phosphorylated form (data not shown). The Ser-539 mutants do not alter pheromone sensitivity, presumably because they are stabilized even without being phosphorylated. How do these findings fit with our understanding of RGS structure-function relationships? The crystal structure determination of rat Gi1α complexed with RGS4 provides some important insights (3Tesmer J.J. Berman D.M. Gilman A.G. Sprang S.R. Cell. 1997; 89: 251-261Abstract Full Text Full Text PDF PubMed Scopus (687) Google Scholar). The RGS core region contains nine α-helices that form two subdomains. The majority of residues that contact Gα are on the “bottom” of the subdomain comprised of helices 4, 5, 6, and 7. A structurally based alignment of RGS4 and Sst2 reveals that Ser-539 lies between helices 6 and 7, on “top” of this subdomain. Thus it appears that Sst2 is phosphorylated at a site distal from the G protein binding interface and therefore would not be expected to have any direct effect on Sst2-Gpa1 interaction. Correspondingly, Sst2 could undergo phosphorylation even in the Gpa1-bound state. This model is consistent with the lack of any G protein modulatory effects of the Ser-539 mutants. There is also the possibility that phosphorylation modulates some other (G protein-independent) function of Sst2. The adjoining region of Sst2 has a 118-amino acid insert (residues 539–657). The function of this region is unknown, but it is probably dispensable for GTPase accelerating activity, since it is absent in all other RGS proteins. Intriguingly, the same insert contains at least two PEST motifs (544–581 and 606–626) (7Dohlman H.G. Song J. Ma D. Courchesne W.E. Thorner J. Mol. Cell. Biol. 1996; 16: 5194-5209Crossref PubMed Google Scholar), which are often found in proteins that are rapidly degraded (29Rechsteiner M. Rogers S.W. Trends Biochem. Sci. 1996; 21: 267-271Abstract Full Text PDF PubMed Scopus (1405) Google Scholar). Perhaps this insert serves as a proteolytic signal, but one which is regulated by pheromone-dependent MAP kinase activity. How do these findings fit with our understanding of MAP kinase function? To our knowledge, this work represents the first direct identification of a MAP kinase phosphorylation site in yeast. It is also a rare example of a MAP kinase substrate outside of the nucleus (30Peter M. Gartner A. Horecka J. Ammerer G. Herskowitz I. Cell. 1993; 73: 747-760Abstract Full Text PDF PubMed Scopus (275) Google Scholar, 31Elion E.A. Satterberg B. Kranz J.E. Mol. Biol. Cell. 1993; 4: 495-510Crossref PubMed Scopus (214) Google Scholar, 32Tyers M. Futcher B. Mol. Cell. Biol. 1993; 13: 5659-5669Crossref PubMed Scopus (141) Google Scholar). In yeast, Fus3 is known to phosphorylate a transcriptional activator (Ste12), transcriptional repressors (Dig1, Dig2), and cyclin inhibitors (30Peter M. Gartner A. Horecka J. Ammerer G. Herskowitz I. Cell. 1993; 73: 747-760Abstract Full Text PDF PubMed Scopus (275) Google Scholar, 33Cook J.G. Bardwell L. Kron S.J. Thorner J. Genes Dev. 1996; 10: 2831-2848Crossref PubMed Scopus (168) Google Scholar, 34Zhang H. Hannon G.J. Beach D. Genes Dev. 1994; 8: 1750-1758Crossref PubMed Scopus (627) Google Scholar). Even in mammalian cells only a handful of non-nuclear substrates for MAP kinases have been identified. However, this list includes members of the GRK and arrestin families, two proteins that promote desensitization of G protein coupled receptors (35Lin F.T. Miller W.E. Luttrell L.M. Lefkowitz R.J. J. Biol. Chem. 1999; 274: 15971-15974Abstract Full Text Full Text PDF PubMed Scopus (121) Google Scholar). 4Robert J. Lefkowitz, personal communication. Thus the regulation of receptors and G proteins may be coordinated in part by the ability of MAP kinases to phosphorylate a variety of desensitization factors acting throughout the signaling pathway. In summary, RGS proteins are well known to promote G protein GTPase activity and desensitization. Our objective was to determine whether RGS proteins are themselves regulated, through post-translational modification. Our demonstration that Sst2 is phosphorylated in response to pheromone stimulation reveals one way that G protein signaling pathways might undergo feedback regulation in vivo. Given the striking similarities in yeast and human RGS proteins, it is likely that the regulatory mechanisms described here will also be recapitulated in more complex organisms. We thank Bill Sessa, Marina Picciotto, and Karen Anderson for advice and Jeannie Hirsch for plasmids. We also thank Jeremy Thorner and undergraduate researchers Thuan Bui, Tom Kraikit, and Houman Fardin for their valuable contributions to the early phases of this project." @default.
- W2010861085 created "2016-06-24" @default.
- W2010861085 creator A5000761684 @default.
- W2010861085 creator A5027497988 @default.
- W2010861085 creator A5040612491 @default.
- W2010861085 creator A5053361384 @default.
- W2010861085 creator A5054063002 @default.
- W2010861085 creator A5076002865 @default.
- W2010861085 date "1999-12-01" @default.
- W2010861085 modified "2023-10-13" @default.
- W2010861085 title "Feedback Phosphorylation of an RGS Protein by MAP Kinase in Yeast" @default.
- W2010861085 cites W1600400967 @default.
- W2010861085 cites W1721292595 @default.
- W2010861085 cites W1971584376 @default.
- W2010861085 cites W1975792086 @default.
- W2010861085 cites W1977667188 @default.
- W2010861085 cites W1980445909 @default.
- W2010861085 cites W1985891609 @default.
- W2010861085 cites W1993485378 @default.
- W2010861085 cites W2006733565 @default.
- W2010861085 cites W2006783888 @default.
- W2010861085 cites W2014000795 @default.
- W2010861085 cites W2037534620 @default.
- W2010861085 cites W2048351462 @default.
- W2010861085 cites W2048743150 @default.
- W2010861085 cites W2050307742 @default.
- W2010861085 cites W2053632669 @default.
- W2010861085 cites W2059572899 @default.
- W2010861085 cites W2071242185 @default.
- W2010861085 cites W2082421715 @default.
- W2010861085 cites W2090440116 @default.
- W2010861085 cites W2092486392 @default.
- W2010861085 cites W2093607662 @default.
- W2010861085 cites W2108280966 @default.
- W2010861085 cites W2135239798 @default.
- W2010861085 cites W2151627279 @default.
- W2010861085 cites W2152899368 @default.
- W2010861085 cites W2165618281 @default.
- W2010861085 cites W4292820908 @default.
- W2010861085 cites W4376848494 @default.
- W2010861085 doi "https://doi.org/10.1074/jbc.274.51.36387" @default.
- W2010861085 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10593933" @default.
- W2010861085 hasPublicationYear "1999" @default.
- W2010861085 type Work @default.
- W2010861085 sameAs 2010861085 @default.
- W2010861085 citedByCount "78" @default.
- W2010861085 countsByYear W20108610852012 @default.
- W2010861085 countsByYear W20108610852013 @default.
- W2010861085 countsByYear W20108610852015 @default.
- W2010861085 countsByYear W20108610852016 @default.
- W2010861085 countsByYear W20108610852017 @default.
- W2010861085 countsByYear W20108610852020 @default.
- W2010861085 countsByYear W20108610852021 @default.
- W2010861085 countsByYear W20108610852022 @default.
- W2010861085 countsByYear W20108610852023 @default.
- W2010861085 crossrefType "journal-article" @default.
- W2010861085 hasAuthorship W2010861085A5000761684 @default.
- W2010861085 hasAuthorship W2010861085A5027497988 @default.
- W2010861085 hasAuthorship W2010861085A5040612491 @default.
- W2010861085 hasAuthorship W2010861085A5053361384 @default.
- W2010861085 hasAuthorship W2010861085A5054063002 @default.
- W2010861085 hasAuthorship W2010861085A5076002865 @default.
- W2010861085 hasBestOaLocation W20108610851 @default.
- W2010861085 hasConcept C11960822 @default.
- W2010861085 hasConcept C185592680 @default.
- W2010861085 hasConcept C2779222958 @default.
- W2010861085 hasConcept C55493867 @default.
- W2010861085 hasConcept C86803240 @default.
- W2010861085 hasConcept C87325107 @default.
- W2010861085 hasConcept C95444343 @default.
- W2010861085 hasConcept C97029542 @default.
- W2010861085 hasConceptScore W2010861085C11960822 @default.
- W2010861085 hasConceptScore W2010861085C185592680 @default.
- W2010861085 hasConceptScore W2010861085C2779222958 @default.
- W2010861085 hasConceptScore W2010861085C55493867 @default.
- W2010861085 hasConceptScore W2010861085C86803240 @default.
- W2010861085 hasConceptScore W2010861085C87325107 @default.
- W2010861085 hasConceptScore W2010861085C95444343 @default.
- W2010861085 hasConceptScore W2010861085C97029542 @default.
- W2010861085 hasIssue "51" @default.
- W2010861085 hasLocation W20108610851 @default.
- W2010861085 hasOpenAccess W2010861085 @default.
- W2010861085 hasPrimaryLocation W20108610851 @default.
- W2010861085 hasRelatedWork W1557660156 @default.
- W2010861085 hasRelatedWork W175922642 @default.
- W2010861085 hasRelatedWork W1970474015 @default.
- W2010861085 hasRelatedWork W1973530967 @default.
- W2010861085 hasRelatedWork W2087084848 @default.
- W2010861085 hasRelatedWork W2352214813 @default.
- W2010861085 hasRelatedWork W2387788458 @default.
- W2010861085 hasRelatedWork W2491608603 @default.
- W2010861085 hasRelatedWork W2505862120 @default.
- W2010861085 hasRelatedWork W4223412920 @default.
- W2010861085 hasVolume "274" @default.
- W2010861085 isParatext "false" @default.
- W2010861085 isRetracted "false" @default.
- W2010861085 magId "2010861085" @default.
- W2010861085 workType "article" @default.